McMillan Shakespeare Limited
ASX: MMS
Investors may book their profits in MMS, but its long-term dividend appeal still remains attractive.
(Source: TradingView) 3-Month Performance Profile of MMS compared to the S&P/ASX 200 (XJO).
McMillan Shakespeare has extended its strong financial growth trajectory into the first half of fiscal year 2025, reporting revenues of $264 million and net earning
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
